Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pretransplant
100%
Radiofrequency Ablation
100%
Hepatocellular Carcinoma
100%
Circulating Tumor Cells
100%
Clinical Indicators
100%
Hepatocellular Carcinoma Patients
44%
Cell Status
22%
San Francisco
11%
Liver Transplantation
11%
Clinical Outcomes
11%
Overall Survival
11%
Multivariate Analysis
11%
Milan Criteria
11%
Overall Survival Rate
11%
Tumor number
11%
Cell Analysis
11%
Kaplan-Meier Analysis
11%
Liver Cirrhosis
11%
University of California
11%
Reliable Indicator
11%
Progression-free
11%
Circulating Tumor Cell Count
11%
Medicine and Dentistry
Radiofrequency Ablation
100%
Hepatocellular Carcinoma
100%
Circulating Tumor Cell
100%
Overall Survival
20%
Neoplasm
10%
Liver Transplantation
10%
Cell Count
10%
Recurrent Disease
10%
Milan Criteria
10%
Survival Rate
10%
Kaplan Meier Method
10%
Liver Cirrhosis
10%
Progression Free Survival
10%
Multivariate Analysis
10%
Independent Factor
10%
Immunology and Microbiology
Circulating Tumor Cell
100%
Radiofrequency
100%
Overall Survival
20%
Survival Rate
10%
Cell Count
10%
Liver Transplantation
10%
Progression Free Survival
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Liver Cell Carcinoma
100%
Overall Survival
18%
Recurrent Disease
9%
Survival Rate
9%
Progression Free Survival
9%
Liver Cirrhosis
9%
Biochemistry, Genetics and Molecular Biology
Radiofrequency
100%
Overall Survival
22%
Progression Free Survival
11%
Survival Rate
11%
Multivariate Analysis
11%
Cell Count
11%